HK1207084A1 - Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors (sglt2) - Google Patents

Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors (sglt2)

Info

Publication number
HK1207084A1
HK1207084A1 HK15107805.3A HK15107805A HK1207084A1 HK 1207084 A1 HK1207084 A1 HK 1207084A1 HK 15107805 A HK15107805 A HK 15107805A HK 1207084 A1 HK1207084 A1 HK 1207084A1
Authority
HK
Hong Kong
Prior art keywords
sglt2
benzylbenzene
inhibitors
sodium
preparation
Prior art date
Application number
HK15107805.3A
Other languages
English (en)
Chinese (zh)
Inventor
Baihua Xu
Binhua Lv
Ge Xu
Brian Seed
Jacques Roberge
Original Assignee
Theracos Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theracos Inc filed Critical Theracos Inc
Publication of HK1207084A1 publication Critical patent/HK1207084A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/16Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms by condensation involving hydroxy groups of phenols or alcohols or the ether or mineral ester group derived therefrom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/16Preparation of ethers by reaction of esters of mineral or organic acids with hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/30Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/12Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
    • C07C39/15Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with all hydroxy groups on non-condensed rings, e.g. phenylphenol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/04Carbocyclic radicals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK15107805.3A 2012-04-10 2015-08-12 Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors (sglt2) HK1207084A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/CN2012/073697 WO2013152476A1 (en) 2012-04-10 2012-04-10 Process for the preparation of benzylbenzene sglt2 inhibitors
PCT/CN2013/072642 WO2013152654A1 (en) 2012-04-10 2013-03-14 Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors

Publications (1)

Publication Number Publication Date
HK1207084A1 true HK1207084A1 (en) 2016-01-22

Family

ID=49326992

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15107805.3A HK1207084A1 (en) 2012-04-10 2015-08-12 Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors (sglt2)

Country Status (16)

Country Link
EP (1) EP2836500A4 (xx)
JP (1) JP6208745B2 (xx)
KR (1) KR102106310B1 (xx)
AR (1) AR090618A1 (xx)
AU (1) AU2013247304B2 (xx)
BR (1) BR112014025105B1 (xx)
CA (1) CA2867057C (xx)
HK (1) HK1207084A1 (xx)
IL (1) IL234800B (xx)
MX (1) MX353307B (xx)
NZ (1) NZ630408A (xx)
RU (1) RU2625795C2 (xx)
SG (1) SG11201406434PA (xx)
TW (1) TWI597289B (xx)
WO (2) WO2013152476A1 (xx)
ZA (1) ZA201406899B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104478675B (zh) * 2015-01-15 2016-01-06 佛山市赛维斯医药科技有限公司 一类含烷氧苯基和三氟甲苯基丙二醇结构的衍生物和用途
CN104478674B (zh) * 2015-01-15 2016-03-09 佛山市赛维斯医药科技有限公司 一类烷氧苯基丙二醇衍生物和用途
CN104478671B (zh) * 2015-01-15 2016-03-09 佛山市赛维斯医药科技有限公司 一类双烷氧苯基丙二醇衍生物和用途
WO2016128995A1 (en) 2015-02-09 2016-08-18 Indoco Remedies Limited Process for the preparation of sglt inhibitor compounds
CZ2015729A3 (cs) * 2015-10-13 2017-04-26 Zentiva, K.S. Příprava intermediátů pro syntézu Canagliflozinu a Dapagliflozinu
CN107641139A (zh) 2016-07-22 2018-01-30 江苏豪森药业集团有限公司 达格列净中间体的晶型及其制备方法
WO2018207111A1 (en) * 2017-05-09 2018-11-15 Piramal Enterprises Limited A process for the preparation of sglt2 inhibitors and intermediates thereof
US20190343853A1 (en) * 2018-04-25 2019-11-14 Theracos Sub, Llc Methods of treating hypertension
CN114570303A (zh) * 2022-03-02 2022-06-03 南京市计量监督检测院 微通道反应器及基于反应器制备达格列净中间体的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI254635B (en) * 2002-08-05 2006-05-11 Yamanouchi Pharma Co Ltd Azulene derivative and salt thereof
US7375213B2 (en) * 2003-01-03 2008-05-20 Bristol-Myers Squibb Company Methods of producing C-aryl glucoside SGLT2 inhibitors
WO2004080990A1 (ja) * 2003-03-14 2004-09-23 Astellas Pharma Inc. C-グリコシド誘導体又はその塩
AR051446A1 (es) * 2004-09-23 2007-01-17 Bristol Myers Squibb Co Glucosidos de c-arilo como inhibidores selectivos de transportadores de glucosa (sglt2)
TW200637839A (en) * 2005-01-07 2006-11-01 Taisho Pharmaceutical Co Ltd 1-thio-d-glucitol derivatives
TW200845956A (en) * 2006-12-18 2008-12-01 Smithkline Beecham Corp Calcilytic compounds
JP2010519273A (ja) 2007-02-21 2010-06-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 四置換グルコピラノシル化ベンゼン誘導体、このような化合物を含む薬物、それらの使用及びそれらの製造方法
JP4809931B2 (ja) * 2007-08-23 2011-11-09 セラコス・インコーポレイテッド ベンジルベンゼン誘導体およびその使用方法
NZ591818A (en) * 2008-08-22 2013-01-25 Theracos Inc Processes for the preparation of sglt2 inhibitors
US9056850B2 (en) * 2008-10-17 2015-06-16 Janssen Pharmaceutica N.V. Process for the preparation of compounds useful as inhibitors of SGLT
BR112012007085B8 (pt) * 2009-09-30 2021-05-25 Boehringer Ingelheim Int processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila
PL2483286T3 (pl) * 2009-09-30 2017-04-28 Boehringer Ingelheim International Gmbh Sposób wytwarzania postaci krystalicznej 1-chloro-4-(β-D-glukopiranoz-1-ylo)-2-[4-((S)-tetrahydrofuran-3-yloksy)-benzylo]-benzenu

Also Published As

Publication number Publication date
RU2014144944A (ru) 2016-06-10
IL234800B (en) 2018-06-28
CA2867057A1 (en) 2013-10-17
EP2836500A4 (en) 2016-03-23
EP2836500A1 (en) 2015-02-18
JP2015514118A (ja) 2015-05-18
AU2013247304A1 (en) 2014-09-25
TWI597289B (zh) 2017-09-01
BR112014025105B1 (pt) 2022-03-29
SG11201406434PA (en) 2014-11-27
MX2014012268A (es) 2015-03-09
JP6208745B2 (ja) 2017-10-04
AR090618A1 (es) 2014-11-26
KR102106310B1 (ko) 2020-05-04
CA2867057C (en) 2020-03-31
NZ630408A (en) 2016-09-30
TW201402593A (zh) 2014-01-16
ZA201406899B (en) 2023-07-26
MX353307B (es) 2018-01-08
BR112014025105A2 (xx) 2017-06-20
AU2013247304B2 (en) 2017-03-30
KR20150001811A (ko) 2015-01-06
WO2013152654A1 (en) 2013-10-17
WO2013152476A1 (en) 2013-10-17
RU2625795C2 (ru) 2017-07-19

Similar Documents

Publication Publication Date Title
HK1207084A1 (en) Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibitors (sglt2)
HK1252424A1 (zh) 鈉葡萄糖協同轉運蛋白1的抑制劑
PL3009010T3 (pl) Sposoby oczyszczania glikozydów stewiolowych
PL2697218T3 (pl) Sposób wytwarzania związków użytecznych, jako inhibitory SGLT2
IL218101A0 (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives
EP2671596A4 (en) PROCESS FOR PREPARING AN AQUEOUS SOLUTION WITH A LIPID SOLUBLE SUBSTANCE
ZA201402281B (en) (4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel madulators
HK1167395A1 (en) C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof c-
EP2859112A4 (en) PROCESS FOR THE PREPARATION OF OLIGOSACCHARIDES AND OLIGOSACCHARIDE GLYCOSIDES BY FERMENTATION
EP2682472A4 (en) METHOD FOR PRODUCING A SUGAR SOLUTION
EP2677042A4 (en) METHOD FOR PRODUCING A SUGAR SOLUTION
IL232418A0 (en) A process for the preparation of beta-c-aryl glucosides
EP2860269A4 (en) PROCESS FOR PRODUCING SUGAR SOLUTION
EP2907799A4 (en) PROCESS FOR THE PREPARATION OF ANHYDROUS SUGAR ALCOHOL
EP2860258A4 (en) METHOD FOR PRODUCING A SUGAR SOLUTION
EP2843061A4 (en) PROCESS FOR PRODUCING SUGAR SOLUTION
EP3020820A4 (en) Method for producing saccharide solution
EP2857528A4 (en) PROCESS FOR PRODUCING SUGAR SOLUTION
EP2832858A4 (en) PROCESS FOR PRODUCING STEVIOL GLYCOSIDE
EP2885282A4 (en) PROCESS FOR THE PREPARATION OF DIHYDRO-2H-PYRANDERIVATES
EP2674500A4 (en) PROCESS FOR PRODUCING SOLID MATERIAL FROM SOLUTION OF SACCHARIDE, AND SOLID MATERIAL
SI2749564T1 (sl) Postopek za pripravo eritromicin tiocianata